Baricitinib 2 mg

Special Anti-rheumatic Agents (Special Anti-rheumatic Agents)

Indication:

Baricitinib is indicated for the treatment of adult patients with moderately to severely active Rheumatoid Arthritis who have had an inadequate response to one or more tumor necrosis factor (TNF) antagonist therapies.

Dosage & Administration:

The recommended dose of Baricitinib is 2 mg once daily. It may be used as monotherapy or in combination with methotrexate or other DMARDs. Baricitinib can be given orally with or without food.

Preparation:

Each box contains 10/20/30/40/50 tablets in blister pack.